may contribute to CRC is its ability to trigger the release of proinflammatory cytokines, including IL-8, IL-6, IL-1β, and TNF-α, which activate multiple signaling pathways involved in tumorigenesis (Figure 1). This evidence concerns the gene TNF and colorectal carcinoma.